| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5¢/kg + 30% |
| 2924.19.11 | 20 | Dimethylformamide | kg | | | |
| 2925.21.00 | 00 | Chlordimeform (ISO) | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4¢/kg + 61% |
| 2925.29.10 | 00 | N'-(4-Chloro-o-tolyl)-N,N- diemthylformamidine; Bunamidine hydrochloride; and Pentamidine | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¢/kg + 41% |
| 2927.00.15 | 00 | 1,1'-Azobisformamide | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P,SG) | 25% |
| 2930.20.20 | 10 | Products used principally for rubber processing | kg | | | |
| 2930.20.90 | 20 | Products used principally for rubber processing | kg | | | |
| 2930.90.91 | 30 | Products used principally for rubber processing | kg | | | |
| 2933.19.30 | 10 | Couplers, for use in color negative photographic paper | kg | | | |
| 2933.19.30 | 15 | Coupler dispersions, for use in color negative photographic paper | kg | | | |
| 2933.69.60 | 30 | Products used principally for rubber processing | kg | | | |
| 2933.99.08 | 00 | Acetoacetyl-5-aminobenzimidazolone; 3-(2H-Benzotriazol-2-yl)-5-(tert-butyl)-4- hydroxybenzene propanoic acid, C7-C9 branched or linear alkyl esters; 2-(2H-Benzotriazol-2-yl)-6-dodecyl-4- methyl phenol, in liquid form, branched and linear; and 1,3,3-Trimethyl-2-methyleneindoline | kg | Free | | 15.4¢/kg + 52% |
| 2936 | | Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent: | | | | |
| 3001 | | Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included: | | | | |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
| 3002.20.00 | 00 | Vaccines for human medicine | kg | Free | | Free |
| 3002.30.00 | 00 | Vaccines for veterinary medicine | kg | Free | | Free |
| 3003 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale: | | | | |
| 3004 | | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: | | | | |
| 3004.10.10 | 10 | For veterinary use | kg | | | |
| 3004.10.50 | 10 | For veterinary use | kg | | | |
| 3004.20.00 | 10 | For veterinary use | kg | | | |
| 3004.39.00 | 10 | For veterinary use | kg | | | |
| 3004.40.00 | 05 | For veterinary use | kg | | | |
| 3004.50.50 | 05 | For veterinary use | kg | | | |
Harmonized Tariff Schedule of the United States inquiry: 3920590000
